MedPath

Study to see the effect of oral intake of Kantakari Kwath in the treatment of Cough

Phase 2
Conditions
Health Condition 1: J398- Other specified diseases of upperrespiratory tract
Registration Number
CTRI/2020/11/029111
Lead Sponsor
Rashmi Kurbet
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients suffering from Kasa(more than 7 days),irrespective of season and prakriti .

Exclusion Criteria

1.Patients with fever or any other COVID symptoms

2.Patients having cough with blood and with complication of Kasa i.e Chronic obstructive Bronchitis,Lung Cancer,Tuberculosis,Bronchiectasis,Lung abscess,Pulmonary edema resulting from Cardiac and Renal disease,Pneumonia will be excluded.

3.Patients with severe form of other systemic disorders like Cardiac disease,Renal failure,CVA,immuno-compromised diseases etc.will be excluded.

4.Pregnant women and lactating mothers.

5.Surgical indication.

6.Kshataj and Kshayaj kasa.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath